IRIS Institutional Research Information System - OPENBS Open Archive UniBS

DE PETRO, Giuseppina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.568
EU - Europa 5.122
AS - Asia 1.964
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 17
SA - Sud America 14
Totale 12.731
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.520
PL - Polonia 1.456
CN - Cina 1.171
DE - Germania 1.002
UA - Ucraina 924
IT - Italia 586
FI - Finlandia 249
FR - Francia 238
GB - Regno Unito 228
HK - Hong Kong 227
SG - Singapore 201
IN - India 195
IE - Irlanda 153
RU - Federazione Russa 103
SE - Svezia 91
VN - Vietnam 75
BE - Belgio 48
CA - Canada 45
TR - Turchia 35
EU - Europa 21
AU - Australia 15
IR - Iran 12
KR - Corea 11
BR - Brasile 10
CZ - Repubblica Ceca 8
MU - Mauritius 7
SD - Sudan 7
TH - Thailandia 7
NL - Olanda 6
RO - Romania 5
ES - Italia 4
BG - Bulgaria 3
ID - Indonesia 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
LY - Libia 3
PT - Portogallo 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
BD - Bangladesh 2
CL - Cile 2
DK - Danimarca 2
EE - Estonia 2
GE - Georgia 2
IL - Israele 2
MA - Marocco 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GR - Grecia 1
IM - Isola di Man 1
JP - Giappone 1
LT - Lituania 1
LV - Lettonia 1
MK - Macedonia 1
MX - Messico 1
OM - Oman 1
RS - Serbia 1
SI - Slovenia 1
SL - Sierra Leone 1
TM - Turkmenistan 1
TZ - Tanzania 1
VE - Venezuela 1
Totale 12.731
Salva come PNG Salva come JPEG
Città #
Warsaw 1.456
Jacksonville 671
Fairfield 604
Woodbridge 469
Chandler 465
Ann Arbor 391
Ashburn 369
Houston 308
Wilmington 290
Princeton 288
Nanjing 264
Cambridge 262
Seattle 228
Hong Kong 223
Beijing 213
Brescia 176
New York 166
Dublin 152
Dearborn 151
Helsinki 129
Singapore 106
Nanchang 91
Shenyang 71
Dong Ket 70
Jinan 68
Hebei 67
Des Moines 63
Changsha 52
Jiaxing 49
Tianjin 47
Milan 46
Brussels 45
Shanghai 45
Lancaster 42
Kunming 39
Pune 32
San Diego 29
Los Angeles 28
Munich 26
Kocaeli 25
Verona 25
Toronto 24
San Francisco 23
Hangzhou 22
Zhengzhou 20
Ningbo 18
North York 18
Nürnberg 17
Boardman 14
London 13
Guangzhou 12
Haikou 12
Lanzhou 12
Lappeenranta 12
Redwood City 12
Romola 12
Norwalk 11
Taizhou 11
Bologna 10
Fuzhou 10
Bari 9
Hefei 9
Orange 9
Melbourne 8
Phoenix 8
Sundbyberg 8
Botucatu 7
Magnago 7
Taiyuan 7
Napoli 6
San Mateo 6
Augusta 5
Borås 5
Brno 5
Brooklyn 5
Castelnuovo Bozzente 5
Naples 5
Pontevico 5
Rockville 5
Washington 5
Berlin 4
Changchun 4
Chicago 4
Copertino 4
Licata 4
Parma 4
San Gregorio Magno 4
Suwon 4
Benghazi 3
Bhubaneswar 3
Daejeon 3
Hat Yai 3
Ho Chi Minh City 3
Indiana 3
Kilburn 3
Melfi 3
Palermo 3
Paris 3
Philadelphia 3
Prescot 3
Totale 8.821
Salva come PNG Salva come JPEG
Nome #
Mutation analysis by direct and whole exome sequencing in familial and sporadic tooth agenesis 313
Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells 277
Environment and bladder cancer: molecular analysis by interaction networks 272
Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells. 214
Analysis of a nanoparticle-enriched fraction of plasma reveals miRNA candidates for Down syndrome pathogenesis 199
Functional Role of microRNA-23b-3p in Cancer Biology 187
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 183
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma 182
Identifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancers 176
RET/PTC-1-driven transformation and pro-invasive phenotype of human thyrocytes depend on MET induction and alpha-catenin nuclear translocation 174
Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. 159
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 155
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 150
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 146
Preparazione di colture primarie di fibroblasti di embrione di pollo . 145
Biological Function of MicroRNA193a-3p in Health and Disease 137
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 137
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 133
miR103 e miR-107 sono coinvolti nella regolazione dell'espressione di CDK5R1/p35 implicato nella migrazione neuronale. 131
Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC 131
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC 131
De novo 1Mb interstitial deletion of 8p22 in a patient with slight mental retardation and speech delay. 131
MicroRNAs as Biomarkers of hepatocellular carcinoma and molecular targeted therapeutics with sorafenib 128
microRNAs and human hepatocellular carcinoma 123
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC. 122
RT-PCR detection of fibronectin EDA+ and EDB+ mRNA isoforms: molecular markers for hepatocellular carcinoma 121
The study of HCC cell specific miRNas reveals one novel human miR and miR-21, miR24 and miR-27a differential expression in HCC 120
The study of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24 and miR-27a differential expression in HCC. 116
LASP1 directly interacts with vimentin and its expression stratifies patients affected by human hepatocellular carcinoma 114
miR24, MiR 27a e miR193a nell'HCC: potenzialità prognostiche e terapeutiche. 110
The analysis of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24, and miR-27a differential expression in cirrhotic/non- cirrhotic HCC. 110
Differential expression profiling of long non-coding RNA GAS5 and miR-126-3p in human cancer cells in response to sorafenib 110
Molecular characterization of LASP-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells. 109
In vitro c-met inhibition by antisense RNA and plasmid -based RNAi down modulates migration and invasion of hepatocellular carcinoma cells. 108
miRNA Editing: New Insights into the Fast Control of Gene Expression in Health and Disease 104
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 101
MicroRNA 193a negatively regulates urokinase and in combination with sorafenib impairs the aggressive properties of HCC cells 101
Sequential analysis of multistage hepatocarcinogenesis reveals that miR100 and PLK1 dysregulation is an early event maintained along tumor progression. 100
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 100
Circulating microRNAs as promising non-invasive molecular biomarkers of HCC 99
Interaction of tissue type plasminogen activator with fibronectin and fibronectin fragments 98
The combined use of miR-193a and sorafenib displays in vitro anticancer effects in hepatocellular carcinoma. 98
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK-1 dysregulation is an early event maintained along tumor progression. 97
The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration. 96
Transformation-enhancing activity of gelatin binding fragments of fibronectin 96
Transformation enhancing activity in plasma of tumor patients: relationship with fibronectin fragments 96
Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells 96
Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy 96
MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. 95
Transformation enhancing activity present in the plasma of cancer patients binds to gelatin. 95
Inhibition of Rous sarcoma virus-induced transformation by proteins involved in blood coagulation 94
A rapid and highly sensitive solid phase enzyme immunoassay specific for human fibronectin using a characterized monoclonal antibody 94
Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients. 93
Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts 91
Gene response of human skin fibroblasts to urokinase- and tissue-type plasminogen activators. 91
Evidence for preferential proteolytic cleavage of one of the two fibronectin subunits and for immunological localization of a site distinguishing them 89
Matrix assembly induction and cell migration and invasion inhibition by a 13-amino acid fibronectin peptide 88
RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice. 85
Role of fibronectin degradation products on cellular transformation. 85
Does miR-338, a putative negative regulator of the facilitative glucose transporter 10 (GLUT10), play a role in arterial tortuosity syndrome? 83
Studi per lo sviluppo di terapie innovative molecolari per l’epatocarcinoma cellulare: microRNA e sorafenib. 83
Tissue-type plasminogen activator but not urokinase exerts transformation enhancing activity 81
Characterization of a 13 aminoacid human fibronectin peptide induce matrix assembly and inhibiting migration and invasion in tumor cells 81
Identification and molecular characterization of cryptic chromosomal rearrangements in mental retardation patients. 81
Antisense u-PA mRNA strategy inhibits the proliferation and invasion of human hepatocellular carcinoma cells. 79
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma. 76
Phosphorylation of human plasminogen activators and plasminogen. 75
Specific downregulation of urokinase by stable expression of antisense u-PA mRNA and u-PA siRNA inhibits proliferation, invasion,and migration of human hepatocellular carcinoma. 73
miRNAs-Based Molecular Signature for KRAS Mutated and Wild Type Colorectal Cancer: An Explorative Study 73
u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor in RNA is down regulated in human hepatocellular carcinoma 73
RT-PCR detection of EDA+ fibronectin mRNA isoforms as hepatocarcinoma markers. 72
Urokinase and c-met are target of miR-23b in human cells. 72
"Trasformazione indotta dai virus oncogeni ad RNA. Tecniche di produzione e titolazione del RSV in colture di fibroblasti di embrione di pollo" pp. 27- 34, settembre 1987, in: , CLEUP-Padova, Italia. 72
Characterization and development of miRNA-like shRNA for urokinase targeting in human hepatocellular carcinoma 71
Urokinase targeting in human hepatocellular carcinoma by shRNAs/miR-23b and proteomic identification of LASP1 as uPA effector. 69
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 69
Androgen receptor mRNA under-expression in poorly differentiated human hepatocellular carcinoma. 67
Genes and MiRNAs in mental retardation patients with cryptic chromosome imbalances detected by SNP-based array analysis. 67
Utilization of Rous sarcoma virus for the detection of transformation enhancing and inhibiting factors in human plasma. 66
MicroRNA ed Epatocarcinoma: il microRNA-23b media la downmodulazione di urochinasi e c-met e la capacità di migrazione di cellule derivate da HCC 66
Il microRNA-23b media la downmodulazione di urochinasi e met ed inibisce la migrazione di cellule umane derivate da epatocarcinoma cellulare. 66
Transformation enhancing factors and fibronectin degradation products as possible tumor markers. 65
FUNCTIONAL ROLE OF MICRORNA-23b-3p and MICRORNA-193a-3p IN CELL MIGRATION OF CANCER CELLS 65
Transformation enhancing factors in vitro and in vivo. Potential as cancer markers 64
Espressione stabile di siRNA per il gene urochinasi nell'epatocarcinoma cellulare 64
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 64
L'espressione stabile della sequenza antisenso dell'mRNA dell'u-PA inibisce la proliferazione e l'invasione di cellule di epatocarcinoma umano. 63
Il silenziamento di urochinasi in cellule tumorali epatiche determina la downmodulazione di Lasp-1 63
The study of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24 and miR-27a differential expression in HCC 63
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 63
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 62
La trascrizione in Molecole, cellule e Organismi 62
Fibronectin and its proteolitic fragments : potential as cancer markers 61
miR-23b down-regulates urokinase and c-met expression and inhibits migration of human hepatocellular carcinoma cells. 61
RNA interference for urokinase gene in human hepatocellular carcinoma 61
L'espressione stabile di RNA antisenso e di siRNA per u-PA inibisce la proliferazione , la migrazione e l'invasione di cellule di epatocarcinoma umano. 61
MicroRNA-23b negatively regulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 60
MET silencing in human hepatocellular carcinoma: antisense and RNA interference 60
Downregulation of urokinase by antisense and RNAi strategies inhibits the proliferation and migration of human hepatocellular carcinoma cells. 60
miR-23b regulates uPA and c-met expression and mediates inhibition of HCC cells migration and proliferation. 59
Totale 10.428
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.740
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.740
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.970 0 0 173 326 188 423 381 377 231 473 204 194
2020/20212.086 57 252 51 252 72 246 95 242 324 203 180 112
2021/20221.186 62 215 56 73 10 41 49 68 67 127 130 288
2022/20231.248 186 64 35 123 119 296 13 104 187 10 48 63
2023/20241.308 95 31 137 75 63 274 83 46 233 53 28 190
2024/2025160 41 67 52 0 0 0 0 0 0 0 0 0
Totale 13.061